Inventor · disambiguated record
Jens-Peter Holck
Also filed as: HOELCK JENS-PETER
9 granted patents·130 citations·filing 1985–1988
88Inventor score
Files withBOEHRINGER MANNHEIM GMBH9
Top patents by PatentIndex Score
9 records- 0186US4882342A5-alkylbenzimidazoles, method of use and pharmaceutical compositionsBOEHRINGER MANNHEIM GMBH·Filed 1987·Granted Nov 21, 1989·48 cites·17 claims
- 0283US4835280AIndoline compounds for synthesis of pharmaceutically active pyrrolobenzimidazolesBOEHRINGER MANNHEIM GMBH·Filed 1987·Granted May 30, 1989·26 cites·13 claims
- 0373US4666923APyrrolobenzimidazoles for treating heart or circulatory diseasesBOEHRINGER MANNHEIM GMBH·Filed 1985·Granted May 19, 1987·17 cites·12 claims
- 0470US4695567APyrrolobenzimidazoles, pharmaceutical compositions containing them and method of using them to treat certain heart and circulatory diseasesBOEHRINGER MANNHEIM GMBH·Filed 1986·Granted Sep 22, 1987·17 cites·18 claims
- 0569US4810801APyrrolobenzimidazoles, pharmaceutical compositions containing them, and use of them to treat certain heart and circulatory diseasesBOEHRINGER MANNHEIM GMBH·Filed 1987·Granted Mar 7, 1989·14 cites·18 claims
- 0654US4710510APyrrolobenzimidazoles, pharmaceutical compositions containing them, and use of them to treat certain heart and circulatory diseasesBOEHRINGER MANNHEIM GMBH·Filed 1985·Granted Dec 1, 1987·6 cites·14 claims
- 0732US4963686ACertain pyridinoylamino-indolin-2-one derivativesBOEHRINGER MANNHEIM GMBH·Filed 1988·Granted Oct 16, 1990·0 cites·13 claims
- 0831US4880805AUse of alkylenediamine derivatives for the treatment of blood flow disturbances and pharmaceutical compositions containing themBOEHRINGER MANNHEIM GMBH·Filed 1988·Granted Nov 14, 1989·1 cites·11 claims
- 0930US4780474AUse of alkylenediamine derivatives for the treatment of blood flow disturbances and pharmaceutical compositions containing themBOEHRINGER MANNHEIM GMBH·Filed 1987·Granted Oct 25, 1988·1 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Jens-Peter Holck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →